# Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety

> **NCT00920387** · PHASE2 · COMPLETED · sponsor: **Multidisciplinary Association for Psychedelic Studies** · enrollment: 12 (actual)

## Conditions studied

- Anxiety

## Interventions

- **DRUG:** 200 mcg LSD
- **DRUG:** 20 mcg LSD
- **BEHAVIORAL:** Therapy

## Key facts

- **NCT ID:** NCT00920387
- **Lead sponsor:** Multidisciplinary Association for Psychedelic Studies
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-04-14
- **Final completion:** 2012-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920387, "Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00920387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*